3 Top Stocks for the Healthcare AI Boom

The AI market could grow twenty-fold by 2030 The AI market could grow twenty-fold by 2030                                                                                                      [Morning Watchlist] You are receiving this email because you are subscribed to Behind the Markets. If you no longer wish to receive these emails, please [unsubscribe]( here. Prefer to view this content on our website? [Click here.]( --------------------------------------------------------------- Dear Fellow Investor, Artificial intelligence (AI) is having a mind-blowing impact on society. We’re already seeing its impact with education, finance, military, cybersecurity, you name it. But this is just the start. Big tech is investing billions in AI. In fact, according to CNBC, AI is now the biggest expense for about half of all tech companies. But again, this is just the start. --------------------------------------------------------------- Chaikin Analytics [Get Your Money Out of U.S. Banks Immediately]( [chaikin]( In 2022, Marc Chaikin warned: "A major shift in our financial system could lead to a RUN ON THE BANKS in 2023." Three months later, we saw the biggest bank failures since 2008. Today, Marc warns it could soon happen again. [Click here to learn more.]( --------------------------------------------------------------- According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – could grow twenty-fold by 2030 to more than $2 trillion. All while the technology massively disrupts everything about everything. That includes healthcare and medical technology. For example, according to analysts over at BlackRock, “The greatest surge of new retirees in the nation’s history is fast approaching, and the AI healthcare market, worth $9 billion in 2022, is forecasted to skyrocket to $188 billion in 2031.” --------------------------------------------------------------- Investing Trends [This CEO sold his first company to Microsoft.]( [laptop ai]( Now he's quietly building a new AI company that the tech giant is already eyeing. Microsoft did their due diligence...and they say this AI company's tech is meeting even their incredibly high bar. [Find out who Microsoft has now vetted.]( --------------------------------------------------------------- Look at drug discovery, for example. At the moment, it can take 10 to 15 years, and upwards of $2 billion to develop a new drug. Plus, designing new drugs isn’t easy.  When creating a new drug, you need to identify a molecule that balances a large number of anti-correlated properties, including potency, selectivity, solubility, bioavailability, clearance/half-life, permeability, drug interactions, and synthesizability. Even then, drug development has a high failure rate of 90% -- which is ridiculously high. However, with artificial intelligence (AI) the rate of failure could drop, and the design of new drugs could become far easier. Some of the top stocks to buy and hold on the healthcare AI trend, include Schrodinger (SYM: SDGR), Exscientia (SYM: EXAI), and Recursion Pharmaceuticals (SYM: RXRX). --------------------------------------------------------------- Investors Alley [Get this Bitcoin ETF before June 26 (18%+ Dividend Yield Up For Grabs)]( [coins]( A massive Bitcoin dividend was just announced... And if you act today, you'll receive $2.05 per SHARE. That's 161% BIGGER than the highest-yielding dividend aristocrats... But you have to get in before the June 26 cutoff date. [Click here now for all the urgent details.]( --------------------------------------------------------------- [Join Daily Guru Trades!]( Want more free daily trades in your inbox? [Sign up for Dylan Jovine's Daily Guru Trades Today.]( Do you have your eye on any healthcare or AI stocks or ETFs we might have missed? Hit "reply" to this email and let us know! Our mailing address is: Behind the Markets, LLC 4260 NW 1st Avenue, Suite 55 Boca Raton, FL 33431 Copyright © 2024 Behind the Markets, LLC, All rights reserved. You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our [Privacy Policy]( or our [Legal Notices.]( We are issuing this disclosure in compliance with Section 17(b) of the Securities Act, which requires us to disclose any compensation received or expected to be received in cash or in kind in connection with the purchase or sale of any security. We would like to inform you that we have received or expect to receive compensation in connection with the purchase or sale of the securities of Railtown AI Technologies Inc. (RLAIF). The compensation consists of up to $1,000 and was received/will be received from Issuer2Investor Marketing Group. This compensation should not be considered as an endorsement of the securities of adviser Railtown AI Technologies Inc. (RLAIF) and we are not responsible for any errors or omissions in any information provided about the securities of Railtown AI Technologies Inc. (RLAIF). We encourage you to conduct your own due diligence and research before making any investment decisions. You should also consult with a financial advisor before making any investment decisions. This disclosure is made as of 6/9/24. [Behind the Markets]( [Unsubscribe](